Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S WARREN

Showing results (961-970 of 1,054) with videos related to

Pageof 106
Sort By:
The Journal of Biological Chemistry|February 7, 2001
Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferationD Q Guo, L W Wu, J D Dunbar, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Assessment of the Drug Interaction Potential of Unconjugated and GalNAc<sub>3</sub>-Conjugated 2'-MOE-ASOsColby S Shemesh, Rosie Z Yu, Mark S Warren, et al.
Transfusion|September 2, 2018
Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allograftsJennifer P Bynum, Andrea Zachary, Paul M Ness, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 13, 2024
Adeno-associated virus-mediated gene delivery of <i>Perm1</i> enhances cardiac contractility in miceKarthi Sreedevi, Alexey V Zaitsev, Abigail Doku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803Monica M Bertagnolli, Robert S Warren, Donna Niedzwiecki, et al.
Pharmacological Research|May 12, 2009
Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including humanMark S Warren, Noa Zerangue, Katie Woodford, et al.
Clinical Transplantation|January 18, 2023
Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of riskJennifer L Alejo, Jake D Kim, Teresa P Y Chiang, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapyO Lomovskaya, M S Warren, A Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803Robert S Warren, Chloe E Atreya, Donna Niedzwiecki, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2008
Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipientsJayme E Locke, Daniel S Warren, Francesca Dominici, et al.
Pageof 106

Showing results (961-970 of 1,054) with videos related to

Sort By:
Pageof 106
The Journal of Biological Chemistry|February 7, 2001
Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferationD Q Guo, L W Wu, J D Dunbar, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Assessment of the Drug Interaction Potential of Unconjugated and GalNAc<sub>3</sub>-Conjugated 2'-MOE-ASOsColby S Shemesh, Rosie Z Yu, Mark S Warren, et al.
Transfusion|September 2, 2018
Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allograftsJennifer P Bynum, Andrea Zachary, Paul M Ness, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 13, 2024
Adeno-associated virus-mediated gene delivery of <i>Perm1</i> enhances cardiac contractility in miceKarthi Sreedevi, Alexey V Zaitsev, Abigail Doku, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803Monica M Bertagnolli, Robert S Warren, Donna Niedzwiecki, et al.
Pharmacological Research|May 12, 2009
Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including humanMark S Warren, Noa Zerangue, Katie Woodford, et al.
Clinical Transplantation|January 18, 2023
Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of riskJennifer L Alejo, Jake D Kim, Teresa P Y Chiang, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapyO Lomovskaya, M S Warren, A Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803Robert S Warren, Chloe E Atreya, Donna Niedzwiecki, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2008
Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipientsJayme E Locke, Daniel S Warren, Francesca Dominici, et al.
Pageof 106